Relevance of such assessment comes from studies indicating that levels of CD40L on immune cells as well as sCD40L are increased in SLE and links to disease activity and activation of B-cells and the type I IFN system have been reported33, 34, 35. This evidence concerns the gene CD40LG and systemic lupus erythematosus.